← Back to Search

Other

Educational Intervention for Breast Cancer

N/A
Waitlist Available
Led By Jasmine A. McDonald, PhD
Research Sponsored by Columbia University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (early trimester 3 i.e. week 27-31 of pregnancy) and follow up 2 (1-month postpartum i.e. approx 3 months from baseline).
Awards & highlights

Summary

This trial is testing if reducing the use of hair care products that contain endocrine disrupting chemicals will help pregnant Women of Color.

Eligible Conditions
  • Breast Cancer
  • Pregnancy
  • Prenatal Exposure

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (early trimester 3 i.e. week 27-31 of pregnancy) and follow up 2 (1-month postpartum i.e. approx 3 months from baseline).
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (early trimester 3 i.e. week 27-31 of pregnancy) and follow up 2 (1-month postpartum i.e. approx 3 months from baseline). for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Internal Dose of Urinary Phthalate Metabolites
Secondary outcome measures
Number of Participants With a Change in PAPM Stage

Trial Design

1Treatment groups
Experimental Treatment
Group I: Educational InterventionExperimental Treatment1 Intervention
All participants receive educational information on the potential health risk of endocrine disruptor chemicals in hair care products, specifically phthalates. Provide information on how to reduce exposure.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Educational Intervention
2013
N/A
~7120

Find a Location

Who is running the clinical trial?

National Institute of Environmental Health Sciences (NIEHS)NIH
286 Previous Clinical Trials
1,232,607 Total Patients Enrolled
2 Trials studying Breast Cancer
51,384 Patients Enrolled for Breast Cancer
Columbia UniversityLead Sponsor
1,448 Previous Clinical Trials
2,531,444 Total Patients Enrolled
29 Trials studying Breast Cancer
23,607 Patients Enrolled for Breast Cancer
Jasmine A. McDonald, PhDPrincipal InvestigatorColumbia University
~11 spots leftby Jul 2025